IOP ED denied as not FDA-approved for this use by Aetna?

Aetna's specific coverage criteria for iop ed are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why Aetna May Deny Eating Disorder IOP as "Not FDA-Approved"

A "not FDA-approved" denial for an eating disorder Intensive Outpatient Program is almost certainly a misapplication of the denial category. The FDA does not "approve" levels of care or behavioral health programs — FDA approval applies to drugs and medical devices, not to psychotherapy-based treatment programs. When this denial language is applied to an IOP, it typically indicates a coding or administrative error, a misclassification of the program as a drug or device rather than a behavioral health service, or a denial template applied without accurate case review.

## Why This Denial Is Appealable

Because the FDA-approval framework does not apply to behavioral health IOP programs, the factual predicate for this denial is incorrect on its face. An appeal that explains why the FDA-approval criterion is inapplicable to this type of service — and documents that IOP is a recognized, guideline-supported level of care — will typically succeed. Additionally, MHPAEA prohibits applying coverage restrictions to mental health and eating disorder care that have no analog in medical/surgical benefit design; applying an "FDA-approved" requirement to a behavioral health program with no comparable requirement for medical programs is a potential parity violation.

## Federal Appeal Framework

• Internal appeal: File within the deadline on your EOB. Specifically challenge the factual basis of the denial: state clearly that the FDA does not regulate behavioral health treatment programs and request the specific policy provision Aetna relied on.
• External review: Under ACA §2719, you have approximately four months from a final internal denial to request an IRO review. An external reviewer will assess whether the denial criterion is lawfully and accurately applied.
• MHPAEA complaint: If Aetna is applying an FDA-approval requirement to eating disorder IOP that does not apply to analogous medical services, file a complaint with your state insurance department or the U.S. Department of Labor.
• Expedited review: If your condition is urgent, request expedited review.

## Documentation to Gather

1. Explanation of applicable regulatory framework: A brief written explanation (from your clinician or attorney if needed) that behavioral health IOP programs are not subject to FDA approval and that the denial criterion is inapplicable. 2. Program accreditation and credentials: Documentation of the IOP program's licensure, state certification, and any accreditation (e.g., The Joint Commission, CARF) demonstrating it meets applicable quality standards. 3. Clinical guideline support: A statement from your treating clinician that the IOP is consistent with the relevant professional organization's guidelines (e.g., APA, Academy for Eating Disorders). 4. Diagnosis and clinical necessity: Chart notes documenting your eating disorder diagnosis and the clinical basis for IOP-level care. 5. Aetna's denial letter and policy: Identify the specific language Aetna used and obtain the underlying policy provision so you can address it directly.

## Criteria-Mapping Structure

Address the inapplicability of the denial criterion first, then map the remaining clinical-coverage requirements from Aetna's policy to your chart facts. This two-part structure — regulatory rebuttal followed by clinical mapping — is the most effective approach for this denial type.